1
|
Mondal T, Mondal S, Ghosh SK, Pal P, Soren T, Pandey S, Maiti TK. Phthalates - A family of plasticizers, their health risks, phytotoxic effects, and microbial bioaugmentation approaches. ENVIRONMENTAL RESEARCH 2022; 214:114059. [PMID: 35961545 DOI: 10.1016/j.envres.2022.114059] [Citation(s) in RCA: 14] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/19/2022] [Revised: 07/18/2022] [Accepted: 08/03/2022] [Indexed: 06/15/2023]
Abstract
Phthalates are a family of reprotoxicant compounds, predominantly used as a plasticizer to improve the flexibility and longevity of consumable plastic goods. After their use these plastic products find their way to the waste disposal sites where they leach out the hazardous phthalates present within them, into the surrounding environment, contaminating soil, groundwater resources, and the nearby water bodies. Subsequently, phthalates move into the living system through the food chain and exhibit the well-known phenomenon of biological magnification. Phthalates as a primary pollutant have been classified as 1B reprotoxicants and teratogens by different government authorities and they have thus imposed restrictions on their use. Nevertheless, the release of these compounds in the environment is unabated. Bioremediation has been suggested as one of the ways of mitigating this menace, but studies regarding the field applications of phthalate utilizing microbes for this purpose are limited. Through this review, we endeavor to make a deeper understanding of the cause and concern of the problem and to find out a possible solution to it. The review critically emphasizes the various aspects of phthalates toxicity, including their chemical nature, human health risks, phytoaccumulation and entry into the food chain, microbial role in phthalate degradation processes, and future challenges.
Collapse
Affiliation(s)
- Tanushree Mondal
- Microbiology Laboratory, Department of Botany, The University of Burdwan, Golapbag, Purba Bardhaman, P. O. -Rajbati, 713104, West Bengal, India.
| | - Sayanta Mondal
- Microbiology Laboratory, Department of Botany, The University of Burdwan, Golapbag, Purba Bardhaman, P. O. -Rajbati, 713104, West Bengal, India.
| | - Sudip Kumar Ghosh
- Microbiology Laboratory, Department of Botany, The University of Burdwan, Golapbag, Purba Bardhaman, P. O. -Rajbati, 713104, West Bengal, India.
| | - Priyanka Pal
- Microbiology Laboratory, Department of Botany, The University of Burdwan, Golapbag, Purba Bardhaman, P. O. -Rajbati, 713104, West Bengal, India.
| | - Tithi Soren
- Microbiology Laboratory, Department of Botany, The University of Burdwan, Golapbag, Purba Bardhaman, P. O. -Rajbati, 713104, West Bengal, India.
| | - Sanjeev Pandey
- Department of Botany, Banwarilal Bhalotia College, Asansol, 713303, West Bengal, India.
| | - Tushar Kanti Maiti
- Microbiology Laboratory, Department of Botany, The University of Burdwan, Golapbag, Purba Bardhaman, P. O. -Rajbati, 713104, West Bengal, India.
| |
Collapse
|
2
|
Wen M, Chen Q, Chen W, Yang J, Zhou X, Zhang C, Wu A, Lai J, Chen J, Mei Q, Yang S, Lan C, Wu J, Huang F, Wang L. A comprehensive review of Rubia cordifolia L.: Traditional uses, phytochemistry, pharmacological activities, and clinical applications. Front Pharmacol 2022; 13:965390. [PMID: 36160419 PMCID: PMC9500525 DOI: 10.3389/fphar.2022.965390] [Citation(s) in RCA: 9] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/09/2022] [Accepted: 07/27/2022] [Indexed: 11/13/2022] Open
Abstract
Rubia cordifolia (family: Rubiaceae) L (R. cordifolia) is a perennial botanical drug climbing vine. As the main part of the traditional Chinese medicine, the rhizome has a long history. A great number of literary studies have reported that it can be used for the improvement of blood circulation, hemostasis, activation of collaterals, etc. When it comes to the wide application of R. cordifolia in traditional medicine, we systematically review its traditional uses, phytochemistry and pharmacological effects. Literatures were systematically searched using several scientific databases, including China National Knowledge Infrastructure (CNKI), Baidu Scholar, PubMed, Web of Science, and other professional websites. Kew Botanical Garden and the iPlant were used for obtaining the scientific names and plant images of R. cordifolia. In addition, other information was also gathered from books including traditional Chinese herbal medicine, the Chinese Pharmacopoeia, and Chinese Materia Medica. So far, many prescriptions containing R. cordifolia have been widely used in the clinical treatment of abnormal uterine bleeding, primary dysmenorrhea and other gynecological diseases, allergic purpura, renal hemorrhage and other diseases. The phytochemistry studies have reported that more than 100 compounds are found in R. cordifolia, such as bicyclic peptides, terpenes, polysaccharides, trace elements, flavonoids, and quinones. Among them, quinones and peptides are the types of components with the highest contents in R. cordifolia. The modern pharmacological studies have revealed that R. cordifolia and its derived components have anti-tumor, anti-oxidative, anti-platelet aggregation, and anti-inflammatory effects. However, most studies are preclinical. The pharmacological mechanism of R. cordifolia has not been thoroughly studied. In addition, there are few pharmacokinetic and toxicity studies of R. cordifolia, therefore the clinical safety data for R. cordifolia is lacking. To sum up, this review for the first time summarizes a systemic and integrated traditional uses, chemical compositions, pharmacological actions and clinical applications of R. cordifolia, which provides the novel and full-scale insight for the drug development, medicinal value, and application of R. cordifolia in the future.
Collapse
Affiliation(s)
- Min Wen
- School of Pharmacy, Southwest Medical University, Luzhou, China
| | - Qi Chen
- Department of Endocrinology and Metabolism, The Affiliated Hospital of Southwest Medical University, Luzhou, China
| | - Wang Chen
- School of Pharmacy, Southwest Medical University, Luzhou, China
| | - Jing Yang
- School of Pharmacy, Southwest Medical University, Luzhou, China
| | - Xiaogang Zhou
- School of Pharmacy, Southwest Medical University, Luzhou, China
| | - Chunxiang Zhang
- Institute of Cardiovascular Research, The Key Laboratory of Medical Electrophysiology, Ministry of Education of China, Medical Key Laboratory for Drug Discovery and Druggability Evaluation of Sichuan Province, Luzhou, China
| | - Anguo Wu
- School of Pharmacy, Southwest Medical University, Luzhou, China
| | - Jia Lai
- School of Pharmacy, Southwest Medical University, Luzhou, China
| | - Jianping Chen
- School of Chinese Medicine, LKS Faculty of Medicine, The University of Hong Kong, Pok Fu Lam, Hong Kong SAR, China
| | - Qibing Mei
- School of Pharmacy, Southwest Medical University, Luzhou, China
| | - Shuo Yang
- School of Pharmacy, Southwest Medical University, Luzhou, China
| | - Cai Lan
- School of Pharmacy, Southwest Medical University, Luzhou, China
| | - Jianming Wu
- School of Pharmacy, Southwest Medical University, Luzhou, China
- Institute of Cardiovascular Research, The Key Laboratory of Medical Electrophysiology, Ministry of Education of China, Medical Key Laboratory for Drug Discovery and Druggability Evaluation of Sichuan Province, Luzhou, China
- *Correspondence: Jianming Wu, ; Feihong Huang, ; Long Wang,
| | - Feihong Huang
- School of Pharmacy, Southwest Medical University, Luzhou, China
- *Correspondence: Jianming Wu, ; Feihong Huang, ; Long Wang,
| | - Long Wang
- School of Pharmacy, Southwest Medical University, Luzhou, China
- *Correspondence: Jianming Wu, ; Feihong Huang, ; Long Wang,
| |
Collapse
|
3
|
Mycosynthesis of novel lactone in foliar endophytic fungus isolated from Bixa orellana L. 3 Biotech 2021; 11:33. [PMID: 33457167 DOI: 10.1007/s13205-020-02566-x] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/09/2020] [Accepted: 11/24/2020] [Indexed: 02/01/2023] Open
Abstract
There is a colossal demand for natural pigments and its applications in recent times. In the study, a novel lactone pigment was isolated from a predominant endophytic fungus residing in Bixa orellana L. (Bixaceae) leaves. The endophyte was identified as Fusarium verticillioides through morphological and molecular investigations. The optimum growth parameters of the endophyte for pigment production were at 33 ºC with pH 6.5 in dark. Through comprehensive spectroscopic studies, the structure of the isolated lactone was resolved and identified as (E)-3, 3-dimethyl-4-(pent-1-en-1-yl)-4-propyldihydrofuran-2(3H)-one. The acute oral toxicity study of the pigment investigated upon female Wistar rats indicated the median lethal dose (LD50) value above 1000 mg/kg body weight affirming safety. Thus, the red pigment from the isolated endophyte may be employed as a sustainable source for natural colorant in industries owing to its non-toxicity. SUPPLEMENTARY INFORMATION The online version contains supplementary material available at 10.1007/s13205-020-02566-x.
Collapse
|
5
|
Gao M, Wang Z, Yang J, Wang L, Wu C, Cui B, Yang C. Simultaneous determination and pharmacokinetics study of four quinones in rat plasma by ultra high performance liquid chromatography with electrospray ionization tandem mass spectrometry after the oral administration of Qianzhi capsules. J Sep Sci 2018; 41:2161-2168. [DOI: 10.1002/jssc.201700981] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/24/2017] [Revised: 01/29/2018] [Accepted: 02/03/2018] [Indexed: 01/24/2023]
Affiliation(s)
- Mingjie Gao
- College of Pharmacy; Harbin Medical University; Harbin P.R. China
| | - Zhibin Wang
- Key Laboratory of Chinese Materia Medical (Ministry of Education); Heilongjiang University of Chinese Medicine; Harbin P.R. China
| | - Jing Yang
- Department of Pathology, School of Basic Medical Science; Heilongjiang University of Chinese Medicine; Harbin P.R. China
| | - Liqian Wang
- College of Pharmacy; Harbin Medical University; Harbin P.R. China
| | - Chengcui Wu
- College of Pharmacy; Harbin Medical University; Harbin P.R. China
| | - Binbin Cui
- College of Pharmacy; Harbin Medical University; Harbin P.R. China
| | - Chunjuan Yang
- College of Pharmacy; Harbin Medical University; Harbin P.R. China
| |
Collapse
|